Advertisement
Advertisement
Trending on NeurologyLive - Clinical Neurology News and Neurology Expert Insights
1
Efgartigimod Meets Primary Endpoint in Phase 3 ALKIVIA Trial of Autoimmune Myositis
2
ATH434's Phase 3 Path Is Set: Alterity on What FDA Alignment Means for MSA
3
Phase 3 BEACON Trial in Angelman Syndrome Gets Underway
4
Building an SMA Care Team That Evolves as Patients Age Into Adulthood
5